These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


336 related items for PubMed ID: 1689353

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes.
    June CH, Ledbetter JA, Lindsten T, Thompson CB.
    J Immunol; 1989 Jul 01; 143(1):153-61. PubMed ID: 2543699
    [Abstract] [Full Text] [Related]

  • 23. Tumor promoters in conjunction with calcium ionophores mimic antigenic stimulation by reactivation of alloantigen-primed murine T lymphocytes.
    Isakov N, Altman A.
    J Immunol; 1985 Dec 01; 135(6):3674-80. PubMed ID: 2999231
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC, Lancki DW, Moldwin RL, Fitch FW.
    J Immunol; 1986 Feb 15; 136(4):1315-21. PubMed ID: 2935576
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
    Tao X, Davis LS, Hashimoto K, Lipsky PE.
    J Pharmacol Exp Ther; 1996 Jan 15; 276(1):316-25. PubMed ID: 8558449
    [Abstract] [Full Text] [Related]

  • 28. FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes.
    Lin CS, Boltz RC, Siekierka JJ, Sigal NH.
    Cell Immunol; 1991 Apr 01; 133(2):269-84. PubMed ID: 1707760
    [Abstract] [Full Text] [Related]

  • 29. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
    Koenen HJ, Michielsen EC, Verstappen J, Fasse E, Joosten I.
    Transplantation; 2003 May 15; 75(9):1581-90. PubMed ID: 12792519
    [Abstract] [Full Text] [Related]

  • 30. Differential effects of the immunosuppressive macrolides FK-506 and rapamycin on activation-induced T-cell apoptosis.
    Staruch MJ, Sigal NH, Dumont FJ.
    Int J Immunopharmacol; 1991 May 15; 13(6):677-85. PubMed ID: 1721613
    [Abstract] [Full Text] [Related]

  • 31. Effects of cyclosporin A, FK 506, and mycalamide A on the activation of murine CD4+ T cells by the murine B7 antigen.
    Galvin F, Freeman GJ, Razi-Wolf Z, Benacerraf B, Nadler L, Reiser H.
    Eur J Immunol; 1993 Jan 15; 23(1):283-6. PubMed ID: 7678228
    [Abstract] [Full Text] [Related]

  • 32. Differential effect of rapamycin and cyclosporin A in proliferation in a murine T cell line expressing either intermediate or high affinity receptor for IL-2.
    Rebollo A, Mérida I, Gómez J, Pitton C, Silva A, Martínez C, García A.
    Cytokine; 1995 Apr 15; 7(3):277-86. PubMed ID: 7543780
    [Abstract] [Full Text] [Related]

  • 33. Cyclosporin A inhibits initiation but not progression of human T cell proliferation triggered by phorbol esters and calcium ionophores.
    Kumagai N, Benedict SH, Mills GB, Gelfand EW.
    J Immunol; 1988 Dec 01; 141(11):3747-52. PubMed ID: 3263432
    [Abstract] [Full Text] [Related]

  • 34. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA, Bird IA, Almawi WY, Rieder MJ.
    J Pharmacol Exp Ther; 1997 Apr 01; 281(1):540-8. PubMed ID: 9103542
    [Abstract] [Full Text] [Related]

  • 35. FK-506 and cyclosporin A: selective inhibition of calcium ionophore-induced polymorphonuclear leukocyte degranulation.
    Forrest MJ, Jewell ME, Koo GC, Sigal NH.
    Biochem Pharmacol; 1991 Aug 22; 42(6):1221-8. PubMed ID: 1716098
    [Abstract] [Full Text] [Related]

  • 36. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A.
    Foxwell BM, Simon J, Herrero JJ, Taylor D, Woerly G, Cantrell D, Ryffel B.
    Immunology; 1990 Jan 22; 69(1):104-9. PubMed ID: 2312149
    [Abstract] [Full Text] [Related]

  • 37. Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway.
    Pereira GM, Miller JF, Shevach EM.
    J Immunol; 1990 Mar 15; 144(6):2109-16. PubMed ID: 1968924
    [Abstract] [Full Text] [Related]

  • 38. The immunosuppressive macrolides FK-506 and rapamycin.
    Thomson AW.
    Immunol Lett; 1991 Jul 15; 29(1-2):105-11. PubMed ID: 1717376
    [Abstract] [Full Text] [Related]

  • 39. Mechanism of action of Cyclosporin A: inhibition of lymphokine secretion studied with antigen-stimulated T cell hybridomas.
    Kaufmann Y, Chang AE, Robb RJ, Rosenberg SA.
    J Immunol; 1984 Dec 15; 133(6):3107-11. PubMed ID: 6436374
    [Abstract] [Full Text] [Related]

  • 40. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.
    Tocci MJ, Matkovich DA, Collier KA, Kwok P, Dumont F, Lin S, Degudicibus S, Siekierka JJ, Chin J, Hutchinson NI.
    J Immunol; 1989 Jul 15; 143(2):718-26. PubMed ID: 2472451
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.